The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. Issue 6 (1st November 2020)
- Record Type:
- Journal Article
- Title:
- The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. Issue 6 (1st November 2020)
- Main Title:
- The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations
- Authors:
- Ivanova, Anastasia
Israel, Elliot
LaVange, Lisa M.
Peters, Michael C.
Denlinger, Loren C.
Moore, Wendy C.
Bacharier, Leonard B.
Marquis, M. Alison
Gotman, Nathan M.
Kosorok, Michael R.
Tomlinson, Chalmer
Mauger, David T.
Georas, Steve N.
Wright, Rosalind J.
Noel, Patricia
Rosner, Gary L.
Akuthota, Praveen
Billheimer, Dean
Bleecker, Eugene R.
Cardet, Juan Carlos
Castro, Mario
DiMango, Emily A.
Erzurum, Serpil C.
Fahy, John V.
Fajt, Merritt L.
Gaston, Benjamin M.
Holguin, Fernando
Jain, Sonia
Kenyon, Nicholas J.
Krishnan, Jerry A.
Kraft, Monica
Kumar, Rajesh
Liu, Mark C.
Ly, Ngoc P.
Moy, James N.
Phipatanakul, Wanda
Ross, Kristie
Smith, Lewis J.
Szefler, Stanley J.
Teague, W. Gerald
Wechsler, Michael E.
Wenzel, Sally E.
White, Steven R.
… (more) - Abstract:
- ABSTRACT: The Precision Interventions for Severe and/or Exacerbation-prone Asthma (PrecISE) study is an adaptive platform trial designed to investigate novel interventions to severe asthma. The study is conducted under a master protocol and utilizes a crossover design with each participant receiving up to five interventions and at least one placebo. Treatment assignments are based on the patients' biomarker profiles and precision health methods are incorporated into the interim and final analyses. We describe key elements of the PrecISE study including the multistage adaptive enrichment strategy, early stopping of an intervention for futility, power calculations, and the primary analysis strategy.
- Is Part Of:
- Journal of biopharmaceutical statistics. Volume 30:Issue 6(2020)
- Journal:
- Journal of biopharmaceutical statistics
- Issue:
- Volume 30:Issue 6(2020)
- Issue Display:
- Volume 30, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 30
- Issue:
- 6
- Issue Sort Value:
- 2020-0030-0006-0000
- Page Start:
- 1026
- Page End:
- 1037
- Publication Date:
- 2020-11-01
- Subjects:
- Master protocol -- platform trial -- covariate adaptive randomization -- adaptive enrichment -- compex -- severe asthma
Pharmacy -- Statistical methods -- Periodicals
Drugs -- Testing -- Statistical methods -- Periodicals
Biometry -- Periodicals
Biopharmaceutics -- Periodicals
Pharmacokinetics -- Periodicals
615.19 - Journal URLs:
- http://www.tandfonline.com/toc/lbps20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/10543406.2020.1821705 ↗
- Languages:
- English
- ISSNs:
- 1054-3406
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4953.910000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22055.xml